Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0460
-0.0010 (-2.13%)
Aug 1, 2025, 3:59 PM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 45.09 million as of August 1, 2025. Its market cap has increased by 30.22% in one year.
Market Cap
45.09M
Enterprise Value
36.72M
Revenue
3.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 45.09M, an increase of 687.75%. That is a compound annual growth rate of 7.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 45.09M | 11.99% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | 42.92M | 78.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.86B |
| Pro Medicus | 32.80B |
| Cochlear | 20.43B |
| Sonic Healthcare | 13.51B |
| Ramsay Health Care | 8.74B |
| Telix Pharmaceuticals | 6.82B |
| Ansell | 4.35B |
| Mesoblast | 3.01B |